Skip to main content
Premium Trial:

Request an Annual Quote

We Call It the Brainiac Gene

Daniel MacArthur posts the highlights from last Friday's sessions at AGBT from Kari Stefansson, John Todd, and Richard Gibbs. Stefansson discussed some unpublished data from Decode, including type 2 diabetes variants that affect a person's risk differently based on whether they are maternally or paternally inherited, as well as a genetic region associated "with a love of crossword puzzles." Todd presented on a gene, IFIH1 with a strong association with a risk of type 1 diabetes and Gibbs talked about the role of rare variants in disease risk. According to MacArthur, Gibbs was genotyped by a personal genomics company and found the information "completely useless."

MacArthur also followed up on his post about Complete Genomics, having spoken to the company's CEO Clifford Reid and CSO Rade Drmanac over the weekend. He goes into more depth about the company's technical approach and business model here.

Filed under

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.